Close Menu

NEW YORK ─ Novacyt on Thursday announced the acquisition of IT-IS International, the exclusive manufacturer of its q16 and q32 rapid PCR instruments.

Paris-based Novacyt will pay £10.1 million ($13.1 million) in cash upfront for the issued share capital of IT-IS and business assets of IT-IS Life Science (Ireland).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.